Withdrawal symptoms during chronic transdermal fentanyl administration managed with oral methadone.
Ripamonti
Carla
C
Campa
Tiziana
T
De Conno
Franco
F
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000328:Adult; D000701:Analgesics, Opioid / Q000008:administration & dosage*; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008691:Methadone / Q000008:administration & dosage*; D008875:Middle Aged; D009020:Morphine / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
D000701:Analgesics, Opioid; D009020:Morphine; D008691:Methadone; D005283:Fentanyl